Systemic Mastocytosis with An Associated Hematologic Neoplasm

• FDA approval · 2021-04-20
  FDA Approved: RYDAPT — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for RYDAPT (midostaurin) from Novartis, updating the regulatory status of the product.